Insider · CIK 0001627810
Michael C Donegan
Files at TXMD (TherapeuticsMD, Inc.). First filing Dec 9, 2022, latest Dec 9, 2022.
In brief
Michael C Donegan files SEC Form 4 as CFO at TXMD (TherapeuticsMD, Inc.). Since Dec 9, 2022, Michael C Donegan has reported 0 open-market buys worth $0 and 1 open-market sell worth $4,345, the latest filed on Dec 9, 2022.
A track record needs three past buys with six months of prices behind them; Michael C Donegan has 0, so none is measured yet.
The newest scored trade: sold $4,345 of TXMD on Dec 6, 2022, filed Dec 9, 2022, scored 27 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TXMD: TherapeuticsMD, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 27Weak | TherapeuticsMD, Inc. | $4,345 910 shares | -17% | +161% from low-77% from high |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 6, 2022 | TXMD TherapeuticsMD, Inc. | MOption exercise Common Stock | +2,300 | $0.00 | $0 | 4,288 | Dec 9, 2022 |
| Dec 6, 2022 | TXMD TherapeuticsMD, Inc. | MOption exercise Common Stock | +380 | $0.00 | $0 | 4,668 | Dec 9, 2022 |
| Dec 6, 2022 | TXMD TherapeuticsMD, Inc. | MOption exercise Common Stock | +534 | $0.00 | $0 | 5,202 | Dec 9, 2022 |
| Dec 6, 2022 | TXMD TherapeuticsMD, Inc. | MOption exercise Common Stock | +262 | $0.00 | $0 | 5,464 | Dec 9, 2022 |
| Dec 6, 2022 | TXMD TherapeuticsMD, Inc. | SOpen-market sale Common Stock | -910 | $4.78 | $4,345 | 4,554 | Dec 9, 2022 |
| Dec 6, 2022 | TXMD TherapeuticsMD, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,300 | $0.00 | $0 | 0 | Dec 9, 2022 |
| Dec 6, 2022 | TXMD TherapeuticsMD, Inc. | MOption exercise Restricted Stock Unitsderivative | -380 | $0.00 | $0 | 380 | Dec 9, 2022 |
| Dec 6, 2022 | TXMD TherapeuticsMD, Inc. | MOption exercise Restricted Stock Unitsderivative | -534 | $0.00 | $0 | 1,066 | Dec 9, 2022 |
| Dec 6, 2022 | TXMD TherapeuticsMD, Inc. | MOption exercise Restricted Stock Unitsderivative | -262 | $0.00 | $0 | 519 | Dec 9, 2022 |
Questions about Michael C Donegan
Answered from the filings on this page, as of the latest one.
Is Michael C Donegan buying or selling?
Not in the last 12 months. Michael C Donegan's latest open-market trade on SEC Form 4 was sold $4,345 of TXMD on Dec 6, 2022.
How did Michael C Donegan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael C Donegan has 0.
Where does Michael C Donegan file Form 4?
Michael C Donegan has filed Form 4 at TXMD (TherapeuticsMD, Inc.) as Interim CFO/CAO/VP of Finance. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.